Pharmacogenomics—the study of genetic influences on an individual's response to therapeutic medications—is an area of personalized medicine that is gaining momentum. Although pharmacogenomics has been around for a while, providers, health plans, pharmacists and legislators are developing a greater appreciation for its potential benefits and applications.
How Can Pharmacogenomics Improve Outcomes?
By considering a person’s DNA in treatment options, providers can determine how an
Read More
Clinical Trial
Power Launches with $7M to Diversify Clinical Trials
What You Should Know:
- Power, a patient-friendly platform designed to improve access to clinical trial studies emerges from stealth with $7M in seed funding.
- The round was led by Footwork and CRV, with additional investments from ARTIS Ventures, South Park Commons, and AirAngels to help Power bring the process of discovering and accessing clinical trials into the future.
Modernising and Simplifying Accessibility to Clinical Trials
Eighty-six percent
Read More
AI More Accurate for Cardiac Diagnosis than Echocardiogram Assessments
What You Should Know:
- In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and the Division of Artificial Intelligence in Medicine at Cedars-Sinai, artificial intelligence (AI) proved more successful in assessing and diagnosing cardiac function when compared to echocardiogram assessments made by sonographers.
- The results, announced during a late-breaking presentation at the European Society of Cardiology Congress 2022, have immediate
Read More
Realizing the Dream of AI in Clinical Trials—How to Address Key Challenges
The clinical development process is incredibly time consuming and only yields a success rate of about 10%. One way to reduce the time, cost and success of the clinical development process is to introduce artificial intelligence (AI) into clinical trials and implement AI-driven process automation.
The dream of AI in clinical trial execution is for trial functions to run autonomously, like a self-driving car. A self-driving car knows how fast it is going, where it needs to go,
Read More
Clarify Health & Datavant Partner to Integrate Real-World Data
What You Should Know:
- Clarify Health, a cloud analytics and value-based payments platform company, and Datavant, a provider helping organizations securely connect health data expands their relationship to enable life sciences companies to connect their proprietary, first-party data in Clarify’s AI-powered Atlas analytics platform to improve clinical development and commercial operations.
- Datavant’s privacy-preserving tokenization and high-accuracy matching technologies will be used to
Read More
H1 Launches AI-Powered and Evidence-Based Interactions
What You Should Know:
- H1, launches an update to its flagship product, HCP Universe, the daily resource for global medical affairs and medical science liaison (MSL) teams.
- New features include a mobile app, Next-gen Smart Search capabilities built on an expansive knowledge graph, out-of-the-box insights tailored to inform MSL and Headquarter decisioning, and AI-powered notifications to improve and accelerate quality HCP engagement.
Establishing AI-Driven Efficient Workflows
H1 is
Read More
H1 & Lokavant Partner to Power Next-Gen Clinical Trials
What You Should Know:
- H1and Lokavant today announced an extensive data-and-analytics collaboration to bring enhanced automated intelligence to drug development
- As part of the bi-directional partnership, Lokavant will provide performance data on global trial sites and principal investigators from thousands of studies to supplement H1’s existing Trial Landscape clinical trial repository.
Integrating Clinical Trial Data Sources to Intelligence Platforms
Lokavant is a clinical
Read More
NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers
What You Should Know:
- NeuroSense Therapeutics Ltd., a company developing treatments for severe neurodegenerative diseases, and NeuraLight, a company developing objective and sensitive biomarkers for neurological disorders, today announced a collaboration to advance the science of digital biomarkers in the detection and monitoring of neurological diseases including amyotrophic lateral sclerosis (ALS).
- This agreement marks NeuraLight’s first clinical trial and comes on the heels of
Read More
Medable Partners with Withings Health Solutions to Integrate Health Devices in Decentralized Clinical Trials
What You Should Know:
- Medable Inc., the leading SaaS platform provider for patient-centered clinical trials, today announced a new partnership with Withings Health Solutions, the business-to-business division of Withings, one of the global leaders in at-home connected health
- Withings’ devices will seamlessly connect to Medable’s decentralized clinical trial platform, reducing the burden on sponsors and sites while empowering patients to participate in trials from home.
Read More
Cornerstone AI Raises $5M to Solve Healthcare’s Data Problem
- Cornerstone AI, a new company solving healthcare’s data challenges to improve research and care, publicly launched its first-of-its-kind AI platform.
- The company also announced a $5M seed round led by Healthy Ventures. The funding marked the first investment for Initiate’s affiliated fund, Initiate Ventures. Healthy Ventures General Partner Anya Schiess and Initiate’s Rowan Chapman and lana Dimkova have joined Cornerstone’s board of directors. Funds will be used to further product
Read More
